Research & Industry Partners

We are pleased to announce that TissueGnostics, a global leader in whole-slide imaging and image analysis, entered into a business partnership with Klein Scientific, an Australia-based scientific equipment distributor, specializing in advanced microscopy systems, reagents and accessories. The partnership aims to strengthen TissueGnostics’s presence in Australia to broaden regional access to end-to-end in situ imaging and analysis workflows.

The project “eRaDicate” is a Horizon-Europe Marie Sklodowska-Curie Doctoral-Network offering an international PhD programme in the cancer field. The scientific aims of eRaDicate are for the PhD candidates to test novel  drugs as anti-cancer agents, such as the retinoic acid receptor (RAR) and the vitamin D receptor (VDR) using a variety of molecular biology and biochemical methods, as well as bioinformatics approaches. The project was launched at the kick-off meeting at TissueGnostics in Vienna from the 7-9.2.2024. 

The Department of General, Visceral and Transplant Surgery at RWTH Aachen University Hospital is recognized as a TG Center of Excellence for its strong and long-standing collaboration. Led by Prof. Klinge and Dr. Dievernich, the team has made significant scientific contributions through numerous high-impact publications using TissueGnostics technologies, as well as active participation in joint webinars and conference activities. »Read the interview with Dr. Axel Dievernich.

The project aims at developing an AI-based decision support system for histopathology, which incorporates and expands TissueGnostics’ solution through development of a deep learning algorithms within a transfer learning framework. The project has received funding within the Austrian Chamber of Commerce’s Life Science Call 2021,  conducted with our partner Software Competence Centre Hagenberg (SCCH).

The Department for Immunology at the LIT – Leibniz Institute for Immunotherapy in Regensburg, Germany, is recognized as a TGCenter of Excellence for its long-standing collaboration since 2012. Led by Prof. Uwe Ritter, the team has made significant scientific contributions through numerous high-impact publications using TissueGnostics technologies. Their continued participation in joint webinars and conference activities exemplify a highly impactful partnership. »Interview with Prof. Uwe Ritter

COMULIS (Correlated Multimodal Imaging in Life Sciences) is a COST (Collaboration in Science and Technology) Action, where TG was among the first members. Due to the successful networking efforts of the COMULIS Consortium, the COST Action was awarded additional funding from COST via the COST Innovators Grant (CIG 17121) MultEMPlex as well as a prestigious grant from the Chan-Zuckerberg-Initiative to expand the collaborations worldwide via COMULISglobe.

The Institute for Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology, and Immunology at the Medical University of Vienna is recognized as a TissueGnostics Center of Excellence for its long-standing collaboration and outstanding scientific contributions. The institute has produced numerous high-impact publications using TissueGnostics technologies and has been actively involved in many collaborative research projects.

VASCage - Research Center on Vascular Aging and Stroke - is a research center based in Innsbruck, focusing on stroke and its most common cause, age-related changes in the blood vessels. VASCage fills a research and market gap between basic and clinical research. In the COMET center VASCage, innovative strategies for diagnosis, therapy and rehabilitation are developed. The partners are world-leading experts from universities, clinics and companies from the EU and the USA, including TissueGnostics.

TissueGnostics, the University Clinic of Dentistry, and the Danube Private University received funding from the Austrian Research Promotion Agency for their project AutOPathStage. The project aims to develop a deep learning-based decision support system for classification of oral dysplasia – a disease of the oral cavity with malignant potential. The project team offered a postdoc position for a computer scientist.

Dr. Nicholas E. Ottone and his team members from Universidad de la Frontera, Chile, acquired TissueFAXS i Plus microscopy platform via the equipment contest FONDEQUIP. They used it for the lastest research and published several scientific papers using the platform to investigate NETotic cells and NETosis. Visit their website to know more about their current research:

The ARC Training Centre for Cell and Tissue Engineering Technologies is a newly funded centre jointly led by Monash University in collaboration with the Queensland University of Technology and incorporates 22 partner organisations, including TissueGnostics.

TissueGnostics is pleased to announce that we have become a new associated company of the Brazilian Society of Microscopy and Microanalysis (SBMM). The Brazilian Society of Microscopy and Microanalysis is the oldest society of microscopy in Latin America. It acts as a key player in the progress of research in Brazil and South America, with a dedication to the advancement of microscopy and microanalysis in all areas of science. We hope that this partnership will substantially contribute to the development of Brazilian science. 

TissueGnostics is a founding sponsor at the AMI Imaging Centre at University of Cape Town, South Africa, funded by Chan Zuckerberg Initiative and the Melinda and Bill Gates Foundation. It is accessible through peer-reviewed proposals, and offers TissueFAXS SL slide scanner for scientists working in Africa.

Funded by the Marie Skłodowska-Curie Actions program, the STOP SPREAD BAD BUGS project is a research training consortium that will train 15 early stage researchers in drug development, infectiology, immunology and pharmacology. TissueGnostics acts as an industry partner, hosting 3 Doctoral Candidates and ready to provide equipment, service and training to the selected researchers in order to facilitate preclinical tests and track the bacteria and antibiotics in the test systems.

The Researcher Exchange and Development within Industry (REDI) Fellowship program supports prominent Australian researchers with entrepreneurism experiences and exposure to strengthen Australia’s successful translation and commercialisation of medical research. Associate Professor Jyotsna Batra, QUT Centre for Genomics and Personalised Medicine, will develop antibodies that detect prostate cancer with TissueGnostics in Vienna.

microONE is a research project elucidating the knowledge gap on the relationship between micro-/nanoplastic particles and cancer. The community of researchers and industry partners including TissueGnostics work together to provide evidence on how different particles influence tumor development and spread by using colorectal cancer (CRC), one of the most frequent tumor entities and prone to contact with micro- and nanoparticles in the gut, as an example.

TissueGnostics is a member of the Euro BioImaging Industry Board (EBIB). In cooperation with other members, TG aims to meet the increasing research needs in the fields of microscopy, molecular imaging, image analysis and tissue cytometry, offering its expertise to expand the boundaries of the current research. The resulting cooperation offers multiple webinars, training opportunities, equipment support and knowledge exchange with the members of Euro Bioimaging Board and European researchers interested in microscopy, digital image analysis and tissue cytometry.

De Novo Software™ has been providing data analysis solutions for cytometry-based research since 1998 with the goal of bridging the gap between image/flow cytometry data acquisition and results. FCS Express™ Image Cytometry, combines a flexible and familiar Microsoft® Office like user interface with extensive image cytometry analysis tools based on flow cytometry analysis workflows. It allows researchers to easily create publication ready charts, and displays coupled with access to advanced statistics, and machine learning tools such as t-SNE, UMAP, FlowSOM. The application enables researchers to move from raw data to understandable, presentation-ready results all while retaining real time linking between images, segmentation masks, and final results.

Oroboros Instruments distributes the gold standard for high-resolution respirometry. Around the world, labs, research centers, hospitals, pharmaceutical and biotech companies use Oroboros O2k technology for their mitochondrial and cell research. Trusted O2k instruments and protocols enable researchers and clinicians to study mitochondrial function in a wide range of applications including cancer, diabetes, aging, neurodegeneration, exercise physiology and mitochondrial medicine.

Deep Learning-based knowledge transfer methods for nuclei segmentation in microscopic images - Austrian Research Promotion Agency funded "Bridge Young Scientists" Project. This project is a collaboration between TissueGnostics, Prof. Isabella Ellinger (Institute for Pathophysiology and Allergy Research, Medical University of Vienna) and Prof. Georg Dorffner (Institute of Artificial Intelligence and Decision Support, Medical University Vienna).

HEalth data LInkage for ClinicAL benefit is a training network comprising 17 academic and 9 non-academic/industry partners for early stage researchers in the field of Healthcare Data Linkage for clinical usage in the GDPR era.

InCeM - Research Training Network on Integrated Component Cycling in Epithelial Cell Motility. Its primary research focus was cell migration, a fundamental biological process occurring throughout the human body at any point in life.

The Medical University of Vienna has coordinated an international research project, which investigated the effectiveness of tried and tested medicines for the treatment of some of the heaviest burdens of our modern society including diseases such as cancer, diabetes and cardiovascular diseases. One molecule that these disorders have in common is a receptor known as the calcium-sensing receptor (CaSR).

The European Research Initiative (ERIA) was instigated to coordinate research into Anaplastic Lymphoma Kinase (ALK)-related malignancies to facilitate the development of less-toxic and more efficacious therapies. ALK is increasingly recognised as a prevalent oncogene in a number of human malignancies and therefore poses a prominent clinical problem.

Academia and Industry Collaboration for Digital Pathology - was an international project focused on developing efficient and innovative products for digital pathology. AIDPATH was an IAPP Marie Curie Action within the European Union’s FP7 Framework Program that went on for four years.